Deshpande Milind 4
4 · Spero Therapeutics, Inc. · Filed Oct 10, 2023
Insider Transaction Report
Form 4
Deshpande Milind
Director
Transactions
- Award
Common Stock
2023-10-05+20,000→ 51,454 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on October 5, 2024, subject to the Reporting Person's continued service through the applicable vesting date.